MAKO Surgical CorpNASDAQ:MAKO
Symbol Lookup
Refresh
Recent News»
0 New Today| Company | Market Cap | P/E Ratio (TTM) | EPS Growth (5yr) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sequenom Inc SQNM | 472.1M | -- | -- | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trinity Biotech PLC TRIB | 368.8M | 21.6x | +31.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Genmark Diagnostics Inc GNMK | 498.1M | -- | -- | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Higher One Holdings Inc ONE | 516.3M | 17.7x | +74.67% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cynosure Inc CYNO | 391.6M | 30.5x | -7.07% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Data delayed 15 minutes. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Information
MAKO Surgical Corp. (MAKO) is a medical device company that markets its robotic arm solution and orthopedic implants for orthopedic procedures called MAKOplasty. The Company offers MAKOplasty, a surgical solution that enables orthopedic surgeons to treat patient specific, osteoarthritic disease. MAKOplasty is performed using its RIO Robotic Arm Interactive Orthopedic system (RIO). The RIO is a technology platform that utilizes tactile guided robotic arm technology and patient specific planning and visualization to offer reproducible precision to surgeons. MAKOplasty procedures are enabled through its technology consisting of the components, which includes RIO system, MAKOplasty applications, and RESTORIS family of implant systems. The RIO is used to treat early to mid-stage osteoarthritic knee disease and osteoarthritic hip disease. During the year ended December 31, 2011, a total of 48 RIO systems were sold worldwide.
| Headquarters | 2555 Davie Road FORT LAUDERDALE, FL, United States 33317 |
|---|---|
| Phone | 954-927-2044 |
| Fax | 954-927-0446 |
EXECUTIVE OFFICERS
| Chairman of the Board, President, Chief Executive Officer | Maurice Ferre |
|---|---|
| Chief Financial Officer, Senior Vice President - Finance and Administration, Treasurer | Fritz LaPorte |
| Senior Vice President, General Counsel, Secretary | Menashe Frank |
| Senior Vice President - Sales | Christopher Marrus |
| Senior Vice President - Marketing | Ivan Delevic |
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
Open a New Account, or Login if you're a client.
(GAAP)*
| Market Cap | $522.9M | Beta | 0.48 |
|---|---|---|---|
| Revenue (TTM) | $107.9M | EPS | $-0.69 |
| Shares Out. | 46.9M | Book Value | $3.02 |
| Dividend Yield | 0.00% | P/E | -- |
| Annual Dividend Rate | $0.00 | Price/Sales (TTM) | 4.8 |
| Ex-Div Date | 1/1/01 | P/Cash Flow (TTM) | -- |
| Pay Date | 1/1/01 | Operating Margin | -30.29% |
*GAAP = prior to non-GAAP analyst adjusted earnings.
(Non-GAAP)*
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
